Find a Clinical Trial | Mary Crowley Cancer Research

Trial Number:

Disease Type:

Molecular Target:

Drug Classification:

Phase:

Search Results

MC# 20-41
A Phase Ia/Ib Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PY159 as a Single Agent and In Combination with Pembrolizumab in Subjects with Advanced Solid Tumors

MC# 19-09
A Phase I, Open-Label, Multiple-Ascending Dose Study of the Safety and Tolerability of CTX-471 Administered Either as a Monotherapy or in Combination with Pembrolizumab in Patients with Inadequate Responses to PD-1/PD-L1 Checkpoint Inhibitors in Metastatic or Locally Advanced Malignancies

MC# 20-06
A Phase I, Open-Label, Dose-Escalation, and Dose-Expansion Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SRK-181 Administered Alone or in Combination with a Checkpoint Inhibitor in Patients with Locally Advanced or Metastatic Solid Tumors

MC# 22-42
A First-in-human, Multicenter, Open-label, Dose Escalation and Dose Expansion Phase I Study in Patients with Advanced Solid Tumors to Evaluate the Safety of Intravenously Administered ALG.APV-527

Ask About Our Clinical Trials

Get Our New App!

Bringing Cancer Clinical Trial Information to the Palm of Your Hand

Why Choose Mary Crowley?

Mary Crowley Cancer Research is a specialized clinical research center that offers access to new investigational therapies through the administration of Phase I and II clinical trials. Our approach is to rapidly advance the discovery of potential new therapies and positively impact the care of cancer patients in their lifetime.

Personalized approach to cancer research
Clinical trials are matched to molecular information found within each cancer patient
Qualified Physician Investigators add to the understanding of what drives cancer and create innovative research applications that attack these drivers
Patient-centric focus brings the newest clinical trial options to patients at a rapid pace